BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31301488)

  • 1. Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient.
    Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Hochman-Mendez C; Junior MC; Zembrzuski VM; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
    Stem Cell Res; 2019 Aug; 39():101490. PubMed ID: 31301488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
    Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
    Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
    Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mRNA-based reprogramming of fibroblasts from a SOD1
    Balez R; Berg T; Bax M; Muñoz SS; Cabral-da-Silva MC; Engel M; Do-Ha D; Stevens CH; Rowe D; Yang S; Blair IP; Ooi L
    Stem Cell Res; 2020 Jan; 42():101701. PubMed ID: 32006803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Generation of induced pluripotent stem cells from amyotrophic lateral sclerosis patientcarrying SOD1-V14M mutation].
    Liu X; Chen J; Li X; Gao S; Deng M
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(27):2143-7. PubMed ID: 25327864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
    Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
    Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
    Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
    Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives.
    Kasai-Brunswick TH; Silva Dos Santos D; Ferreira RP; Araujo DS; Dias GM; Coutinho JLA; Cruz FESF; Sternick EB; Gubert F; Oliveira JCG; Vaz IM; Borgonovo T; Brofman PRS; Moura-Neto RS; Silva R; Campos-de-Carvalho AC; Carvalho AB
    Stem Cell Res; 2018 Aug; 31():174-180. PubMed ID: 30099333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
    Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
    Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
    Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
    Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of twelve induced pluripotent stem cell lines from two healthy controls and two patients with sporadic amyotrophic lateral sclerosis.
    Yang M; Liu M; Ding Y; Vajda A; Ma J; Cui H; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2020 Apr; 44():101752. PubMed ID: 32208303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF
    Bax M; Balez R; Muñoz SS; Do-Ha D; Stevens CH; Berg T; Cabral-da-Silva MC; Engel M; Nicholson G; Yang S; Blair IP; Ooi L
    Stem Cell Res; 2019 Oct; 40():101530. PubMed ID: 31445393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
    Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
    Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells from neonatal mouse cochlear cells.
    Du D; Lou X
    Differentiation; 2014; 87(3-4):127-33. PubMed ID: 24582575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
    Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
    Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
    Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.